← back to search

James T. Koerber

Research & Diagnostic Antibodies (United States) · US
Area of research
Radiology, Nuclear Medicine and Imaging · Molecular Biology
Research interest
Research interests include Monoclonal and Polyclonal Antibodies Research, Virus-based gene therapy research, RNA Interference and Gene Delivery, and Glycosylation and Glycoproteins Research.
h-index
29
citations
4,710
works
79
NIH funding
primary concept
email

Recent publications

Complete inhibition of β-tryptase by tetramer dissociation and active site allostery due to a single antibody residue
Nature Communications 2026cited by 1position: middledoi
Engineering a protease-stable, oral single-domain antibody to inhibit IL-23 signaling
Proceedings of the National Academy of Sciences 2025cited by 8position: lastdoi
Preclinical and translational pharmacology of afucosylated anti‐CCR8 antibody for depletion of tumour‐infiltrating regulatory T cells
British Journal of Pharmacology 2024cited by 10position: middledoi
Combined PD-L1/TGFβ blockade allows expansion and differentiation of stem cell-like CD8 T cells in immune excluded tumors
Nature Communications 2023cited by 88position: middledoi
Structural basis of antibody inhibition and chemokine activation of the human CC chemokine receptor 8
Nature Communications 2023cited by 27position: middledoi
Structure of the core human NADPH oxidase NOX2
Nature Communications 2022cited by 101position: lastdoi
Loss of the intracellular enzyme QPCTL limits chemokine function and reshapes myeloid infiltration to augment tumor immunity
Nature Immunology 2022cited by 38position: middledoi
Genome-wide association study identifies kallikrein 5 in type 2 inflammation-low asthma
Journal of Allergy and Clinical Immunology 2022cited by 15position: middledoi
Systematic pharmacological analysis of agonistic and antagonistic fibroblast growth factor receptor 1 MAbs reveals a similar unique mode of action
Journal of Biological Chemistry 2022cited by 2position: middledoi
Antibody toolkit reveals N-terminally ubiquitinated substrates of UBE2W
Nature Communications 2021cited by 22position: lastdoi
Bivalent antibody pliers inhibit β-tryptase by an allosteric mechanism dependent on the IgG hinge
Nature Communications 2020cited by 42position: lastdoi
Effect of Modulating FcRn Binding on Direct and Pretargeted Tumor Uptake of Full-length Antibodies
Molecular Cancer Therapeutics 2020cited by 14position: middledoi
An Allosteric Anti-tryptase Antibody for the Treatment of Mast Cell-Mediated Severe Asthma
Cell 2019cited by 109position: middledoi
A targeted boost-and-sort immunization strategy using Escherichia coli BamA identifies rare growth inhibitory antibodies
Scientific Reports 2018cited by 37position: lastdoi
Quantitative Proteomics Reveal a Feedforward Mechanism for Mitochondrial PARKIN Translocation and Ubiquitin Chain Synthesis
Molecular Cell 2014cited by 707position: middledoi
An Improved Single-Chain Fab Platform for Efficient Display and Recombinant Expression
Journal of Molecular Biology 2014cited by 55position: firstdoi
Structural snapshots reveal distinct mechanisms of procaspase-3 and -7 activation
Proceedings of the National Academy of Sciences 2013cited by 79position: middledoi
Nature-inspired design of motif-specific antibody scaffolds
Nature Biotechnology 2013cited by 73position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

James A. Wells · University of California, San Francisco4 papers (2013–2014)C. Davies · University of California, Berkeley4 papers (2020–2025)Tangsheng Yi · Howard Hughes Medical Institute3 papers (2020–2025) · 3 papers (2018–2026)Laëtitia Comps‐Agrar · Gene Therapy Laboratory3 papers (2018–2023)Sascha Rutz · Gilead Sciences (United States)3 papers (2022–2024)Jian Payandeh · Exelixis (United States)3 papers (2018–2023)Robert A. Lazarus · Gene Therapy Laboratory2 papers (2020–2026) · 2 papers (2020–2026) · 2 papers (2018–2025) · 2 papers (2022–2023) · 2 papers (2022–2024)Matthieu Masureel · Gene Therapy Laboratory2 papers (2022–2023) · 2 papers (2022–2023)Naruhisa Ota · Gene Therapy Laboratory2 papers (2022–2025)N.D. Thomsen · Gilead Sciences (United States)2 papers (2013–2013)Yonglian Sun · Shandong University2 papers (2022–2023)Teresita L. Arenzana · Biogen (United States)2 papers (2023–2024)Henry R. Maun · Gene Therapy Laboratory2 papers (2020–2026) · 2 papers (2018–2023)